减少注射部位疼痛与改变pH在24小时复合的肉毒毒素:从一个随机对照研究的发现化品应用
Kenan Kherallah1, Mohammed G Turkmani2, Nabil Fakih-Gomez3
1Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Aesthetic plastic surgery
|October 11, 2024
概括
在一项临床试验中,通过将其复制为24小时,调整肉毒素 (BTX) 的pH值显著减少了注射部位疼痛 (ISP). 这种pH值修改提供了一个有希望的,简单的策略,以提高在整形手术期间的患者舒适度.
科学领域:
- 审美学 在审美学方面
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 毒素 (BTX) 注射在化品治疗中很受欢迎.
- 注射部位疼痛 (ISP) 是一个常见的挑战,影响患者的满意度.
- 需要新的方法来缓解与BTX程序相关的不适.
研究的目的:
- 调查是否改变复制的肉毒毒素的pH值可以减少注射部位的疼痛.
- 与新鲜BTX相比,评估24小时再制成的BTX配方在减轻疼痛方面的有效性.
主要方法:
- 进行了一项随机对照试验,共有24名参与者.
- 进行了毒素A的注射;一侧接受了新鲜毒素,另一侧接受了24小时的复制毒素.
- 使用视觉模拟尺度 (VAS) 量化疼痛.
主要成果:
- 与新鲜毒素 (6.17) 相比,24小时复制的毒素具有更高的pH值 (7.17).
- 大多数参与者 (13人中24人) 报告说,复制后的毒素减少了疼痛.
- 复制毒素 (4.17) 与新鲜毒素 (5.92) (p<0.01) 的平均VAS分数显著较低.
结论:
- 通过24小时的溶解来改变毒素的pH值,显示了减少注射部位疼痛的潜力.
- 这种pH调整提供了一种可行的策略,可以提高BTX治疗期间的患者体验.
- 建议进行进一步的大规模研究,以全面验证这种减少疼痛的技术.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
658
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
658
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
371
Intravenous regional anesthesia or the Bier block technique is used to anesthetize a specific limb or extremity. It uses exsanguinated or blood-drained vessels to transport local anesthetics or LAs to the peripheral nerve trunks. Lidocaine without vasoconstrictors like epinephrine is most commonly used for this technique. Other drugs used are prilocaine, ropivacaine, and chloroprocaine. Bupivacaine is not recommended for this technique due to its high cardiac toxicity.
One of the advantages of...
One of the advantages of...
371
Local Anesthetics: Clinical Application as Spinal Anesthesia
587
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
587
Local Anesthetics: Chemistry and Structure-Activity Relationship
4.3K
Local anesthetics (LAs) are drugs that induce a temporary loss of sensation in a limited body area, preventing pain. Cocaine was the first local anesthetic discovered in the late 19th century. Cocaine is a benzoic acid ester obtained from the leaves of coca shrubs and was often used for its psychotropic effects. Cocaine was first isolated in 1860 by Albert Niemann. Sigmund Freud studied the physiological actions of cocaine. Carl Koller later introduced it into clinical practice in 1884 as a...
4.3K
Depolarizing Blockers: Pharmocokinetics
313
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
313
Local Anesthetics: Pharmacokinetics
738
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
738


